231 related articles for article (PubMed ID: 28041919)
1. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.
Mekori-Domachevsky E; Guri Y; Yi J; Weisman O; Calkins ME; Tang SX; Gross R; McDonald-McGinn DM; Emanuel BS; Zackai EH; Zalsman G; Weizman A; Gur RC; Gur RE; Gothelf D
Schizophr Res; 2017 Oct; 188():42-49. PubMed ID: 28041919
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
[TBL] [Abstract][Full Text] [Related]
3. Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.
Weisman O; Guri Y; Gur RE; McDonald-McGinn DM; Calkins ME; Tang SX; Emanuel B; Zackai EH; Eliez S; Schneider M; Schaer M; Kates WR; Antshel KM; Fremont W; Shashi V; Hooper SR; Armando M; Vicari S; Pontillo M; Kushan L; Jalbrzikowski M; Bearden CE; Cubells JF; Ousley OY; Walker EF; Simon TJ; Stoddard J; Niendam TA; van den Bree MBM; Gothelf D;
Schizophr Bull; 2017 Sep; 43(5):1079-1089. PubMed ID: 28204757
[TBL] [Abstract][Full Text] [Related]
4. Inter-rater reliability of subthreshold psychotic symptoms in individuals with 22q11.2 deletion syndrome.
Moore TM; Salzer D; Bearden CE; Calkins ME; Kates WR; Kushan L; Gallagher RS; Frumer DS; Weinberger R; McDonald-McGinn DM; Gur RE; Gothelf D
J Neurodev Disord; 2021 Jun; 13(1):23. PubMed ID: 34126928
[TBL] [Abstract][Full Text] [Related]
5. Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder.
Shapiro DI; Cubells JF; Ousley OY; Rockers K; Walker EF
Schizophr Res; 2011 Jun; 129(1):20-8. PubMed ID: 21507614
[TBL] [Abstract][Full Text] [Related]
6. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes.
Zarchi O; Diamond A; Weinberger R; Abbott D; Carmel M; Frisch A; Michaelovsky E; Gruber R; Green T; Weizman A; Gothelf D
Eur Psychiatry; 2014 May; 29(4):203-10. PubMed ID: 24054518
[TBL] [Abstract][Full Text] [Related]
8. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
[TBL] [Abstract][Full Text] [Related]
9. Comparing the broad socio-cognitive profile of youth with Williams syndrome and 22q11.2 deletion syndrome.
Weisman O; Feldman R; Burg-Malki M; Keren M; Geva R; Diesendruck G; Gothelf D
J Intellect Disabil Res; 2017 Dec; 61(12):1083-1093. PubMed ID: 28990288
[TBL] [Abstract][Full Text] [Related]
10. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
[TBL] [Abstract][Full Text] [Related]
11. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
12. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.
Parker DA; Cubells JF; Imes SL; Ruban GA; Henshey BT; Massa NM; Walker EF; Duncan EJ; Ousley OY
BMC Psychiatry; 2023 Jun; 23(1):425. PubMed ID: 37312091
[TBL] [Abstract][Full Text] [Related]
13. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
Stoddard J; Niendam T; Hendren R; Carter C; Simon TJ
Schizophr Res; 2010 May; 118(1-3):118-21. PubMed ID: 20056393
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications.
Mekori-Domachevsky E; Taler M; Weinberger R; Guri Y; Dar S; Shani S; Dekel I; Weizman A; Gothelf D
Schizophr Res; 2021 May; 231():164-169. PubMed ID: 33866261
[TBL] [Abstract][Full Text] [Related]
15. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
[TBL] [Abstract][Full Text] [Related]
16. Subthreshold social cognitive deficits may be a key to distinguish 22q11.2DS from schizophrenia.
Peyroux E; Rigard C; Saucourt G; Poisson A; Plasse J; Franck N; Demily C
Early Interv Psychiatry; 2019 Apr; 13(2):304-307. PubMed ID: 29575660
[TBL] [Abstract][Full Text] [Related]
17. Mother-Child Interaction as a Window to a Unique Social Phenotype in 22q11.2 Deletion Syndrome and in Williams Syndrome.
Weisman O; Feldman R; Burg-Malki M; Keren M; Geva R; Diesendruck G; Gothelf D
J Autism Dev Disord; 2015 Aug; 45(8):2567-77. PubMed ID: 25791124
[TBL] [Abstract][Full Text] [Related]
18. Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.
Donnelly NA; Bartsch U; Moulding HA; Eaton C; Marston H; Hall JH; Hall J; Owen MJ; van den Bree MBM; Jones MW
Elife; 2022 Aug; 11():. PubMed ID: 36039635
[TBL] [Abstract][Full Text] [Related]
19. Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
Basel D; Mosheva M; Maeder J; Schneider M; Shani S; Weinberger R; Eliez S; Gothelf D
Eur Child Adolesc Psychiatry; 2022 Sep; 31(9):1367-1375. PubMed ID: 33871687
[TBL] [Abstract][Full Text] [Related]
20. Identifying patterns of anxiety and depression in children with chromosome 22q11.2 deletion syndrome: comorbidity predicts behavioral difficulties and impaired functional communications.
Stephenson DD; Beaton EA; Weems CF; Angkustsiri K; Simon TJ
Behav Brain Res; 2015 Jan; 276():190-8. PubMed ID: 24906195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]